Nurse Practitioner Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Anna Payne

Nurse Practitioner, Obstetrics & Gynecology Park Ridge, IL Nurse Practitioner

NPI 1952054363 CMS profile 11384573

1875 Dempster St Ste 245, Park Ridge, IL 60068

Open in the dashboard

General payments

$1,895

81 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anna Payne of Park Ridge, IL is reported in the CMS Open Payments database as having received $1,895 across 81 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Nurse Practitioner, Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $251 8
2024 General $568 26
2023 General $575 26
2022 General $501 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anna Payne
  • Nurse Practitioner, Obstetrics & Gynecology median
  • Middle half of Nurse Practitioner, Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Anna Payne were reported at $251. Among 1,030 Nurse Practitioner, Obstetrics & Gynecology profiles paid that year, the median was $151 and the middle half received between $51 and $371.

Show as a table
Year Anna Payne Nurse Practitioner, Obstetrics & Gynecology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $135 $40–$338 $132
2022 $501 $143 $45–$386 $149
2023 $575 $153 $54–$411 $160
2024 $568 $140 $45–$326 $164
2025 $251 $151 $51–$371 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Novo Nordisk Inc $352 16 payments
  2. Mayne Pharma Inc. $253 8 payments
  3. Sumitomo Pharma America, Inc. $200 7 payments
  4. Exeltis, USA Inc. $146 8 payments
  5. Hologic, LLC $120 6 payments
  6. Biohaven Pharmaceutical Holding Company Ltd. $105 1 payment
  7. CooperSurgical, Inc. $100 5 payments
  8. Pfizer Inc. $97 5 payments
  9. Agile Therapeutics, Inc. $91 4 payments
  10. Myovant Sciences Inc. $82 3 payments
  11. Other $350 18 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $1,895 81 payments
Products named General payments · program years 2022–2025
  1. MYFEMBREE $253 9 payments
  2. Wegovy $202 7 payments
  3. BIJUVA $106 1 payment
  4. NURTEC ODT $105 1 payment
  5. Twirla $91 4 payments
  6. SLYND Oral contraceptive $75 4 payments
  7. Aptima $73 4 payments
  8. PARAGARD T 380A $61 3 payments
  9. ABRYSVO $52 2 payments
  10. SLYND Contraceptive $50 3 payments
  11. Other $872 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

81 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Obstetrics & Gynecology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record